related documents
- Asthma outcomes with benralizumab in biologic-naive and biologic-experienced patients with severe eosinophilic asthma (SEA) in an integrated analysis of the real-world XALOC-1 study Conferences
- Clinical remission in patients with severe eosinophilic asthma with benralizumab according to body mass index status in an integrated analysis of the real-world XALOC-1 study Conferences
- Complete response to upadacitinib in a patient with treatment-resistant symptomatic dermographism Conferences
- Multiplatform metabolomics of cow's milk-allergic infants, their mothers, and grandmothers reveals changes in faecal amino acids, bile acids and branched-chain fatty acids Conferences